前收市價 | 32.15 |
開市 | 32.31 |
買盤 | 34.03 x 100 |
賣出價 | 34.18 x 600 |
今日波幅 | 31.70 - 35.47 |
52 週波幅 | 17.53 - 59.84 |
成交量 | |
平均成交量 | 911,209 |
市值 | 2.62B |
Beta 值 (5 年,每月) | 0.67 |
市盈率 (最近 12 個月) | 無 |
每股盈利 (最近 12 個月) | -7.69 |
業績公佈日 | 2024年8月01日 - 2024年8月05日 |
遠期股息及收益率 | 無 (無) |
除息日 | 無 |
1 年預測目標價 | 28.27 |
PTC Therapeutics shows improving price performance, earning an upgrade to its IBD Relative Strength Rating
PTC Therapeutics, Inc. (NASDAQ:PTCT) Q1 2024 Earnings Call Transcript April 25, 2024 PTC Therapeutics, Inc. beats earnings expectations. Reported EPS is $-1.2, expectations were $-1.31. PTC Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day and thank […]
Although the revenue and EPS for PTC Therapeutics (PTCT) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.